Original Research

Published on 24 Jul 2024

CT morphological features and histogram parameters to predict micropapillary or solid components in stage IA lung adenocarcinoma

in Thoracic Oncology

Qin Chen
Kaihe Lin
Baoteng Zhang
Youqin Jiang
Suying Wu
Jiajun Lin

Frontiers in Oncology

doi 10.3389/fonc.2024.1448333

686 views

Original Research

Published on 16 Jul 2024

Neoadjuvant targeted therapy versus targeted combined with chemotherapy for resectable EGFR-mutant non–small cell lung cancer: a retrospective controlled real-world study

in Thoracic Oncology

Weipeng Shao
Zhan Liu
Bobo Li
Feng Chen
Jie Liu
Hui Li
Hongbo Guo

Frontiers in Oncology

doi 10.3389/fonc.2024.1349300

1,401 views

Review

Published on 16 Jul 2024

Optimization of treatment strategies for elderly patients with advanced non-small cell lung cancer

in Thoracic Oncology

Qiang Chen
Shuo Ying
Jianwen Qin
Li Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1384906

1,092 views

Systematic Review

Published on 15 Jul 2024

Toxicity of immune checkpoint inhibitors and tyrosine kinase inhibitor combinations in solid tumours: a systematic review and meta-analysis

in Thoracic Oncology

David O’Reilly
Caroline L. O’Leary
Aislinn Reilly
Min Yuen Teo
Grainne O’Kane
Lizza Hendriks
Kathleen Bennett
Jarushka Naidoo

Frontiers in Oncology

doi 10.3389/fonc.2024.1380453

1,752 views

Original Research

Published on 12 Jul 2024

Association between obstructive sleep apnea and risk of lung cancer: findings from a collection of cohort studies and Mendelian randomization analysis

in Thoracic Oncology

Jun Yao
Ran Duan
Qingyuan Li
Ruonan Mo
Pengcheng Zheng
Tong Feng

Frontiers in Oncology

doi 10.3389/fonc.2024.1346809

1,194 views

Case Report

Published on 11 Jul 2024

Case report: Pathological complete response to neoadjuvant brigatinib in stage III non-small cell lung cancer with ALK rearrangement

in Thoracic Oncology

Hayoung Seong
Soo Han Kim
Mi Hyun Kim
Jeong Su Cho
Ahrong Kim
Jung Seop Eom

Frontiers in Oncology

doi 10.3389/fonc.2024.1343238

864 views

Review

Published on 11 Jul 2024

Understanding the treatment response and resistance to targeted therapies in non-small cell lung cancer: clinical insights and perspectives

in Thoracic Oncology

Hang Zhang
Yingying Zhang
Yingying Zhu
Tian Dong
Zheng Liu

Frontiers in Oncology

doi 10.3389/fonc.2024.1387345

1,622 views

Case Report

Published on 09 Jul 2024

A case report of recurrent testicular germ cell tumor in a patient with a history of primary pulmonary germ cell tumor and a review of the literature

in Thoracic Oncology

Jian Tan
Jinfeng Wu
Runqiang Yuan
Wei Li
Linfeng Li
Hongxing Huang
Yangbai Lu

Frontiers in Oncology

doi 10.3389/fonc.2024.1361380

695 views

Systematic Review

Published on 09 Jul 2024

Immune-related adverse events in patients treated with immunotherapy for locally advanced or metastatic NSCLC in real-world settings: a systematic review and meta-analysis

in Thoracic Oncology

Giulia Pasello
Alberto Pavan
Mattia De Nuzzo
Stefano Frega
Alessandra Ferro
Alessandro Dal Maso
Laura Bonanno
Valentina Guarneri
Fabio Girardi

Frontiers in Oncology

doi 10.3389/fonc.2024.1415470

1,475 views

Original Research

Published on 09 Jul 2024

Tissue- and liquid-biopsy based NGS profiling in advanced non-small-cell lung cancer in a real-world setting: the IMMINENT study

in Thoracic Oncology

Marco Sposito
Lorenzo Belluomini
Riccardo Nocini
Jessica Insolda
Ilaria Mariangela Scaglione
Jessica Menis
Michele Simbolo
Antonio Lugini
Federica Buzzacchino
Francesco Verderame

Frontiers in Oncology

doi 10.3389/fonc.2024.1436588

2,114 views
2 citations

Case Report

Published on 08 Jul 2024

Challenges in the treatment of BRAF K601E-mutated lung carcinoma: a case report of rapid response and resistance to dabrafenib and trametinib

in Thoracic Oncology

Akihiro Nishiyama
Shigeki Sato
Hiroyuki Sakaguchi
Hiroshi Kotani
Kaname Yamashita
Koushiro Ohtsubo
Shigeki Nanjo
Seiji Yano
Keishi Mizuguchi
Hiroko Ikeda

Frontiers in Oncology

doi 10.3389/fonc.2024.1374594

885 views

Original Research

Published on 08 Jul 2024

Camrelizumab combined with anlotinib as second-line therapy for metastatic or recurrent small cell lung cancer: a retrospective cohort study

in Thoracic Oncology

Shujing Shen
Xingya Li
Sanxing Guo
Liang Xu
Ningning Yan

Frontiers in Oncology

doi 10.3389/fonc.2024.1391828

831 views
1 citation

Case Report

Published on 08 Jul 2024

Case report: Pulmonary sarcomatoid carcinoma demonstrating rapid growth on follow-up CT

in Thoracic Oncology

Li Tu
Hong Xie
Lianshan Zhan
Yushi Yang
Tingting Chen
Na Hu
Xiaojun Du
Shi Zhou

Frontiers in Oncology

doi 10.3389/fonc.2024.1393203

739 views

Case Report

Published on 08 Jul 2024

Repeating late-phase pseudo-progression in a patient with non-small cell lung cancer treated with long-term nivolumab monotherapy; a case report

in Thoracic Oncology

Rikako Ebisuda
Naoki Furuya
Takeo Inoue
Shotaro Kaneko
Yu Numata
Yusuke Shinozaki
Masamichi Mineshita

Frontiers in Oncology

doi 10.3389/fonc.2024.1353698

859 views

Original Research

Published on 05 Jul 2024

Immune checkpoint inhibitor increased mortality in lung cancer patients with Pneumocystis jirovecii pneumonia: a comparative retrospective cohort study

in Thoracic Oncology

Bo Fan
Xiaoyan Sun
Weijie Han
Yimin Zou
Fei Chen
Fen Lan
Wen Li
Yanxiong Mao

Frontiers in Oncology

doi 10.3389/fonc.2024.1398357

940 views

Review

Published on 04 Jul 2024

Comparative analysis of medical glue and positioning hooks for preoperative localization of pulmonary nodules

in Thoracic Oncology

Haowen Wang
Min Deng
Dexin Cheng
Rui Feng
Hanbo Liu
Tingyang Hu
Dongdong Liu
Cheng Chen
Peilin Zhu
Jian Shen

Frontiers in Oncology

doi 10.3389/fonc.2024.1392213

634 views

Navigation group

Articles

CT morphological features and histogram parameters to predict micropapillary or solid components in stage IA lung adenocarcinoma

Neoadjuvant targeted therapy versus targeted combined with chemotherapy for resectable EGFR-mutant non–small cell lung cancer: a retrospective controlled real-world study

Optimization of treatment strategies for elderly patients with advanced non-small cell lung cancer

Toxicity of immune checkpoint inhibitors and tyrosine kinase inhibitor combinations in solid tumours: a systematic review and meta-analysis

Association between obstructive sleep apnea and risk of lung cancer: findings from a collection of cohort studies and Mendelian randomization analysis

Case report: Pathological complete response to neoadjuvant brigatinib in stage III non-small cell lung cancer with ALK rearrangement

Understanding the treatment response and resistance to targeted therapies in non-small cell lung cancer: clinical insights and perspectives

A case report of recurrent testicular germ cell tumor in a patient with a history of primary pulmonary germ cell tumor and a review of the literature

Immune-related adverse events in patients treated with immunotherapy for locally advanced or metastatic NSCLC in real-world settings: a systematic review and meta-analysis

Tissue- and liquid-biopsy based NGS profiling in advanced non-small-cell lung cancer in a real-world setting: the IMMINENT study

Challenges in the treatment of BRAF K601E-mutated lung carcinoma: a case report of rapid response and resistance to dabrafenib and trametinib

Camrelizumab combined with anlotinib as second-line therapy for metastatic or recurrent small cell lung cancer: a retrospective cohort study

Case report: Pulmonary sarcomatoid carcinoma demonstrating rapid growth on follow-up CT

Repeating late-phase pseudo-progression in a patient with non-small cell lung cancer treated with long-term nivolumab monotherapy; a case report

Immune checkpoint inhibitor increased mortality in lung cancer patients with Pneumocystis jirovecii pneumonia: a comparative retrospective cohort study

Comparative analysis of medical glue and positioning hooks for preoperative localization of pulmonary nodules